Nectar Lifescience Ltd Share Price
As on 18 November 2025 at 23:49 IST
The Current prices are delayed, log in for live prices
LOGINOver 1 Month
8.39%
Over 6 Months
-39.82%
Over 1 Year
-59.10%
Over 3 Years
-28.26%
Nectar Lifescience Ltd Summary
Close ₹14.60
Open ₹14.75
High ₹14.90
Low ₹14.01
Volume 8,34,827
Net Turnover (in Cr) ₹1.2
52Wk High ₹44.41
52Wk Low ₹13.05
52Wk High / Low
13.05
44.41
Nectar Lifescience Ltd Fundamentals
Key Financial Data
Market Cap (in Cr) ₹327.42
EPS (TTM) -
Book Value (BV) 31.97
Div. Yield -
P/E (TTM) -0.91
Price/Book Value 0.46
Delivery % 62.43 %
Face Value 1
Key Ratios
PE Ratio -
PB Ratio 0.54
EV to Sales 0.65
PEG Ratio -
ROA -7.35
ROE -11.23
Debt-Equity 0.60
Net Profit Margin -5.96
Operating Profit Margin -1.29
Nectar Lifescience Ltd Financials
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 1,674.96 | 1,698.66 | 1,566.85 | 1,680.15 | 1,547.09 |
| Total Expenses | 1,836.50 | 1,680.39 | 1,609.27 | 1,646.07 | 1,606.54 |
| Profit Before Tax | -161.53 | 18.27 | -42.42 | 34.08 | -84.77 |
| Profit After Tax | -113.68 | 5 | -24.18 | 25.05 | -73.26 |
| Operating Profit After Depreciation | -86.96 | 105.41 | 37.07 | 112.89 | 52.58 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 633.11 | 642.71 | 661.97 | 723.10 | 771.89 |
| Total Non Current Assets | 809.64 | 907.23 | 958.03 | 1,035.98 | 1,149.29 |
| Total Current Assets | 1,237.59 | 1,283.83 | 1,231.18 | 1,354.85 | 1,238.83 |
| Total Assets | 2,047.22 | 2,191.06 | 2,189.21 | 2,390.83 | 2,388.11 |
| Total Shareholder's Fund | 956.11 | 1,069.25 | 1,064.59 | 1,087.90 | 1,062.03 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 169.44 | 224.69 | 133.65 | 95.01 | 21.38 |
| Net Cash Used In Investing Activities | -41.93 | -17.03 | 51.70 | 16.64 | -28.62 |
| Net Cash Used In Financing Activities | -128.09 | -205.44 | -185.58 | -119.38 | 11.49 |
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 1,674.96 | 1,698.66 | 1,566.85 | 1,679.55 | 1,545.62 |
| Total Expenses | 1,836.50 | 1,680.39 | 1,607.54 | 1,645.20 | 1,604.95 |
| Profit Before Tax | -161.53 | 18.28 | -40.69 | 34.35 | -84.65 |
| Profit After Tax | -113.68 | 5 | -22.46 | 25.32 | -73.15 |
| Operating Profit After Depreciation | -86.96 | 105.42 | 38.78 | 113.16 | 52.70 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 633.11 | 642.71 | 661.97 | 723.10 | 771.89 |
| Total Non Current Assets | 809.65 | 907.23 | 958.04 | 1,035.95 | 1,149.25 |
| Total Current Assets | 1,237.58 | 1,283.83 | 1,231.17 | 1,353.75 | 1,237.57 |
| Total Assets | 2,047.23 | 2,191.06 | 2,189.21 | 2,389.71 | 2,386.82 |
| Total Shareholder's Fund | 956.11 | 1,069.25 | 1,064.60 | 1,086.86 | 1,060.73 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 169.44 | 224.69 | 133.37 | 95.04 | 21.33 |
| Net Cash Used In Investing Activities | -41.93 | -17.03 | 52.03 | 16.64 | -28.62 |
| Net Cash Used In Financing Activities | -128.09 | -205.44 | -185.57 | -119.38 | 11.49 |
| Particulars (in ₹ Cr.) | 2025-09 | 2025-06 | 2025-03 | 2024-12 | 2024-09 |
|---|---|---|---|---|---|
| Total Revenue | 5.71 | 5.24 | 430.69 | 454.98 | 5.73 |
| Total Expenses | 181.72 | 68.63 | 585 | 410.28 | 6.32 |
| Profit Before Tax | -176.18 | -63.60 | -187.67 | 12.54 | 5.48 |
| Profit After Tax | -176.01 | -63.23 | -130.09 | 7.84 | 5.60 |
| Operating Profit after Depreciation | -175.98 | -63.07 | -154.23 | 45.27 | 5.93 |
| Particulars (in ₹ Cr.) | 2025-09 | 2025-06 | 2025-03 | 2024-12 | 2024-09 |
|---|---|---|---|---|---|
| Total Revenue | 5.71 | 5.24 | 430.69 | 454.98 | 5.73 |
| Total Expenses | 181.72 | 68.63 | 585 | 410.28 | 6.32 |
| Profit Before Tax | -176.18 | -63.60 | -187.67 | 12.54 | 5.48 |
| Profit After Tax | -176.01 | -63.23 | -130.09 | 7.84 | 5.60 |
| Operating Profit after Depreciation | -175.98 | -63.07 | -154.23 | 45.27 | 5.93 |
Nectar Lifescience Ltd Technicals
Support and Resistance
S3 S2 S1 Pivot R1 R2 R3
S1 14.11
S2 13.61
S3 13.22
Pivot 14.50
R1 15
R2 15.39
R3 15.89
Moving Average
20 SMA 14.46
50 SMA 14.66
100 SMA 16.04
200 SMA 20.98
Nectar Lifescience Ltd Corporate Actions
No available data
Nectar Lifescience Ltd Peer Comparison
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Sun Pharmaceutical Industries Ltd | ₹1,763.70 | ₹4,23,170.71 |
| Divis Laboratories Ltd | ₹6,523.25 | ₹1,73,171.79 |
| Torrent Pharmaceuticals Ltd | ₹3,816.75 | ₹1,29,170.36 |
| Cipla Ltd | ₹1,536.25 | ₹1,24,093.85 |
| Dr Reddys Laboratories Ltd | ₹1,244.50 | ₹1,03,868.61 |
Nectar Lifescience Ltd Top Mutal Funds Invested
| Fund Name | AUM |
|---|---|
| Bandhan BSE Healthcare Index Fund | 0.01% |
Nectar Lifescience Ltd News
Nectar Lifescience announces board meeting date
On 14 November 2025
10 Nov 2025, 10:41 am
Nectar Lifescience to convene AGM
On 29 September 2025
28 Aug 2025, 01:45 pm
Nectar Lifescience schedules board meeting
On 14 August 2025
11 Aug 2025, 01:48 pm
Nectar Lifescience to hold board meeting
On 23 July 2025
21 Jul 2025, 09:45 am
Nectar Lifescience Ltd leads losers in 'B' group
Lokesh Machines Ltd, Rhetan TMT Ltd, Vibhor Steel Tubes Ltd and Dreamfolks Services Ltd are among the other losers in the BSE's 'B' group today, 09 July 2025.
09 Jul 2025, 02:45 pm
Nectar Lifescience Ltd Stock Analysis
- Annual revenue for Nectar Lifescience Ltd decreased by 1.40% to ₹1,674.96 crore in FY 2025 from ₹1,698.66 crore in FY 2024.
- Annual Net Profit for Nectar Lifescience Ltd decreased by 2372.71% to ₹-113.68 crore in FY 2025 from ₹5 crore in FY 2024.
- Promoter Shareholding in Nectar Lifescience Ltd increased by 0.84% in the most recent quarter, from 44.53% in June 2025 to 44.91% in September 2025.
- Nectar Lifescience Ltd delivered a 1-year return of -59.10% compared to the Nifty 50, which provided a return of 10.91% as of the last trading session.
- Nectar Lifescience Ltd share price moved down by 0.62% from its previous close of INR ₹14.60. The latest Nectar Lifescience Ltd share price is INR ₹14.51.
- Nectar Lifescience Ltd share price today has been at a low of 14.37 and a high of 14.95. Over the past 52 weeks, the Nectar Lifescience Ltd share price has seen a low of 13.05 and a high of 44.41.
FAQ’s
What is the share price of Nectar Lifescience Ltd today?
Nectar Lifescience Ltd share price as on 18 Nov 2025 is ₹ 14.51
What is the Market Cap of Nectar Lifescience Ltd?
The market cap of Nectar Lifescience Ltd stock is ₹327.42 Cr.
What is the PE Ratio of Nectar Lifescience Ltd?
The Price to Earnings (P/E) Ratio of Nectar Lifescience Ltd is -
What is the PB Ratio of Nectar Lifescience Ltd?
The Price to Book (P/B) Ratio of Nectar Lifescience Ltd is 0.54
What is the 52 week high of Nectar Lifescience Ltd Share Price?
The 52 week high of Nectar Lifescience Ltd share price stands at ₹44.41
What is the 52 week low of Nectar Lifescience Ltd Share Price?
The 52 week low of Nectar Lifescience Ltd share price stands at ₹13.05
How can I buy shares of Nectar Lifescience Ltd?
Simply open a demat account with Torus Digital and place an order to buy shares of Nectar Lifescience Ltd.
Open FREE
3-in-1 Account
for all your banking, trading and demat needs
Trade in stocks,
derivatives and F&O
